Faradarmani Consciousness Field Suppresses Alzheimer’s Disease Development in both in vitro and in vivo Models of the Disease

Main Article Content

Mohammad Ali Taheri
Sara Torabi
Noushin Nabavi
Farid Semsarha


Alzheimer’s Disease; Faradarmani Consciousness Field; Taheri Consciousness Fields; TBI; mice model; neural cell model


Alzheimer’s Disease (AD) is one of the most common causes of dementia, imposing large financial and psychological burdens on nations worldwide. Thus, we direly need new treatment strategies or drugs for this disease. The aim of this study is to investigate the effects of a novel non-pharmacological method in the treatment of Alzheimer’s disease, based on employing Taheri Consciousness Fields. These fields function at the level of cellular and molecular processes. In this study, the effects of Faradarmani Consciousness Field (CF) on the AD mouse model (in vivo) and human neuron cell line in vitro were investigated. In this study, we established a human neuron cell culture as well as a traumatic brain injury (TBI) mouse model. We then measured changes in amyloidopathy, tau protein content, microtubule assembly, neuronal cell survival, and finally behavior of TBI mice in Elevated Plus Maze under treatment of the Faradarmani CF. According to the results, the treatment of human neural cells and a mouse model of Alzheimer's disease by the Faradarmani CF leads to complete survival of neural cell models and elimination of amyloidopathy and tau protein, and remarkable behavioral improvement of the treated TBI mice model in the elevated plus-maze. Based on the results, Faradarmani CF treatment suppresses AD development in laboratory models. In this regard, conducting a human clinical study with the aim of introducing a new global complementary and alternative medicine in AD treatment is highly recommended.

Abstract 88 | PDF Downloads 41